The drug manufacturing industry is a lucrative sector for investors seeking growth opportunities. With increasing demand for pharmaceutical products and advancements in medical technology, drug manufacturers are well-positioned to capitalize on rising healthcare needs. Stocks in this industry are highly influenced by factors such as regulatory approvals, patent expirations, and market competition. Investors can analyze financial performance, pipeline of new drugs, and market trends to make informed decisions when investing in drug manufacturer stocks. Overall, the drug manufacturing industry presents a promising prospect for investors looking to diversify their portfolio and tap into the booming healthcare sector.
| Symbol | Exchange | Name | MCAP | Price | Change | PE Ratio | Yield |
|---|---|---|---|---|---|---|---|
| AMRN | NASDAQ | Amarin Corp PLC | 0.22B | 0.54 | 2.71 | 522.38 | 0.00 |
| TLRY | NASDAQ | Tilray Brands Inc | 1.10B | 1.18 | 0.00 | 27.97 | 0.00 |
| CRDL | NASDAQ | Cardiol Therapeutics Inc. - Class A Common Shares | 0.10B | 1.23 | 1.66 | 0.00 | 0.00 |
| OGI | NASDAQ | Organigram Holdings Inc. - Common Shares | 0.20B | 1.55 | -1.28 | 0.00 | 0.00 |
| PROC | NASDAQ | Procaps Group SA | 0.18B | 1.62 | -5.27 | 3.24 | 0.00 |
| CRON | NASDAQ | Cronos Group Inc. - Common Share | 0.75B | 1.95 | 4.28 | 18.70 | 0.00 |
| AKBA | NASDAQ | Akebia Therapeutics Inc | 0.43B | 1.98 | -2.95 | 0.00 | 0.00 |
| CGC | NASDAQ | Canopy Growth Corporation - Common Shares | 0.27B | 2.20 | -1.35 | 0.00 | 0.00 |
| ESPR | NASDAQ | Esperion Therapeutics Inc | 0.45B | 2.28 | -2.57 | 0.00 | 0.00 |
| ORGO | NASDAQ | Organogenesis Holdings Inc | 0.42B | 3.33 | -0.15 | 63.14 | 0.00 |
| IRWD | NASDAQ | Ironwood Pharmaceuticals Inc | 0.59B | 3.71 | -1.60 | 54.80 | 0.00 |
| AQST | NASDAQ | Aquestive Therapeutics Inc | 0.35B | 3.89 | -6.72 | 0.00 | 0.00 |
| ACB | NASDAQ | Aurora Cannabis Inc. - Common Shares | 0.22B | 3.96 | -1.74 | 0.00 | 0.00 |
| SIGA | NASDAQ | SIGA Technologies Inc | 0.46B | 6.39 | -0.16 | 5.38 | 0.00 |
| LFCR | NASDAQ | Lifecore Biomedical Inc | 0.24B | 6.48 | 0.63 | 40.17 | 0.00 |
| GRFS | NASDAQ | Grifols, S.A. - American Depositary Shares | 4.92B | 7.24 | -3.08 | 29.36 | 0.00 |
| BHC | NYSE | Bausch Health Companies Inc. Common Stock | 2.81B | 7.65 | 1.06 | 1.84 | 0.00 |
| TKNO | NASDAQ | Alpha Teknova Inc | 0.41B | 7.65 | -3.48 | 0.00 | 0.00 |
| AMRX | NASDAQ | Amneal Pharmaceuticals Inc | 2.55B | 8.22 | 4.72 | 93.83 | 0.00 |
| HLN | NYSE | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | 41.87B | 9.26 | 0.17 | 28.80 | 0.02 |
| EBS | NYSE | Emergent BioSolutions Inc | 0.51B | 9.46 | 1.07 | 7.11 | 0.00 |
| AVDL | NASDAQ | Avadel Pharmaceuticals PLC | 0.96B | 10.00 | -1.48 | 34.13 | 0.00 |
| EOLS | NASDAQ | Evolus Inc | 0.67B | 10.61 | 5.37 | 31.65 | 0.00 |
| INDV | NASDAQ | Indivior PLC - Ordinary Shares | 1.47B | 11.85 | -1.99 | 1,095.77 | 0.00 |
| ELAN | NYSE | Elanco Animal Health Inc | 6.11B | 12.36 | -1.83 | 29.46 | 0.00 |
| ETON | NASDAQ | Eton Pharmaceuticals Inc | 0.33B | 12.51 | 2.88 | 20.58 | 0.00 |
| VTRS | NASDAQ | Viatris Inc | 14.93B | 12.51 | -2.27 | 4.15 | 0.04 |
| DVAX | NASDAQ | Dynavax Technologies Corp | 1.68B | 12.76 | -1.40 | 84.93 | 0.00 |
| ALVO | NASDAQ | Alvotech | 4.00B | 13.26 | -0.75 | 0.00 | 0.00 |
| HCM | NASDAQ | HUTCHMED (China) Limited - American Depositary Shares | 2.28B | 13.33 | -3.76 | 72.46 | 0.00 |
| TAK | NYSE | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 42.45B | 13.39 | 0.68 | 22.30 | 0.05 |
| RDY | NYSE | Dr. Reddy's Laboratories Ltd Common Stock | 11.79B | 14.15 | -6.23 | 18.82 | 0.01 |
| OGN | NYSE | Organon & Co | 4.11B | 15.97 | -2.69 | 3.16 | 0.07 |
| ANIK | NASDAQ | Anika Therapeutics Inc | 0.24B | 16.37 | -0.79 | 34.72 | 0.00 |
| PCRX | NASDAQ | Pacira BioSciences Inc | 0.91B | 19.76 | 3.51 | 7.01 | 0.00 |
| KNSA | NASDAQ | Kiniksa Pharmaceuticals International PLC | 1.48B | 20.51 | 3.72 | 129.19 | 0.00 |
| PAHC | NASDAQ | Phibro Animal Health Corp | 0.84B | 20.82 | -0.53 | 50.95 | 0.02 |
| TEVA | NYSE | Teva Pharmaceutical Industries Limited American Depositary Shares | 24.56B | 21.68 | -1.19 | 7.74 | 0.00 |
| PRGO | NYSE | Perrigo Co PLC | 3.28B | 24.05 | -1.64 | 8.10 | 0.04 |
| PFE | NYSE | Pfizer Inc | 145.30B | 25.64 | 1.07 | 34.79 | 0.06 |
| ALKS | NASDAQ | Alkermes PLC | 4.61B | 28.47 | -1.97 | 13.62 | 0.00 |
| COLL | NASDAQ | Collegium Pharmaceutical Inc | 0.95B | 29.53 | 3.18 | 13.93 | 0.00 |
| GSK | NYSE | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | 68.06B | 33.36 | -0.24 | 22.86 | 0.05 |
| AMPH | NASDAQ | Amphastar Pharmaceuticals Inc | 1.74B | 36.14 | 0.30 | 12.13 | 0.00 |
| SUPN | NASDAQ | Supernus Pharmaceuticals Inc | 2.03B | 36.74 | 0.17 | 36.11 | 0.00 |
| HROW | NASDAQ | Harrow Inc | 1.40B | 39.32 | 5.08 | 103.35 | 0.00 |
| SNY | NASDAQ | Sanofi - American Depositary Shares | 127.21B | 50.74 | 2.78 | 28.07 | 0.04 |
| BMY | NYSE | Bristol-Myers Squibb Co | 116.68B | 57.53 | 2.21 | 8.50 | 0.04 |
| ANIP | NASDAQ | ANI Pharmaceuticals Inc | 1.23B | 58.44 | 0.49 | 9.47 | 0.00 |
| CTLT | NYSE | Catalent Inc | 11.52B | 63.48 | 0.00 | 0.00 | 0.00 |
| AZN | NASDAQ | AstraZeneca PLC - American Depositary Shares | 207.80B | 67.01 | 0.65 | 33.28 | 0.02 |
| PBH | NYSE | Prestige Consumer Healthcare Inc | 3.63B | 73.47 | -1.23 | 18.70 | 0.00 |
| LNTH | NASDAQ | Lantheus Holdings Inc | 6.33B | 90.98 | -1.73 | 16.20 | 0.00 |
| GILD | NASDAQ | Gilead Sciences Inc | 114.43B | 91.82 | 0.90 | 1,034.11 | 0.03 |
| MRK | NYSE | Merck & Co Inc | 243.63B | 96.31 | -2.09 | 19.99 | 0.03 |
| NVS | NYSE | Novartis AG Common Stock | 195.75B | 97.91 | 0.06 | 17.45 | 0.04 |
| NVO | NYSE | Novo Nordisk A/S Common Stock | 464.40B | 104.59 | -3.71 | 29.73 | 0.02 |
| ITCI | NASDAQ | Intra-Cellular Therapies Inc | 13.44B | 126.54 | 0.27 | 322.58 | 0.00 |
| NBIX | NASDAQ | Neurocrine Biosciences Inc | 14.61B | 144.29 | 0.73 | 39.66 | 0.00 |
| JNJ | NYSE | Johnson & Johnson | 347.66B | 144.40 | -0.05 | 25.36 | 0.03 |
| BIIB | NASDAQ | Biogen Inc | 22.49B | 154.33 | 0.70 | 13.22 | 0.00 |
| ZTS | NYSE | Zoetis Inc | 76.07B | 168.61 | 0.99 | 31.69 | 0.01 |
| ABBV | NYSE | AbbVie Inc | 310.43B | 175.67 | -0.51 | 59.34 | 0.04 |
| AMGN | NASDAQ | Amgen Inc | 149.37B | 277.88 | 1.63 | 35.17 | 0.03 |
| LLY | NYSE | Eli Lilly and Co | 675.41B | 751.03 | -0.32 | 84.63 | 0.01 |
The drug manufacturing industry is a vital part of the healthcare sector, producing medications that treat a wide range of illnesses and conditions. Investing in drug manufacturer stocks can be appealing to many investors due to the essential nature of the products these companies produce and the potential for significant returns. In this article, we'll explore the ins and outs of investing in drug manufacturers industry stocks.
There are several reasons why investing in drug manufacturer stocks can be a wise choice. These companies often have stable revenue streams, as demand for medications is generally consistent regardless of economic conditions. Additionally, many drug manufacturers have a strong track record of innovation, continuously developing new treatments and technologies.
While investing in drug manufacturer stocks can be rewarding, it also carries certain risks. The industry is highly regulated, and companies can face challenges gaining approval for new medications or navigating changing healthcare policies. Additionally, patent expirations and competition from generic drug manufacturers can impact a company's profitability.
Investing in drug manufacturer stocks can be a way to add diversity to your portfolio and potentially benefit from the healthcare sector's growth. Before investing, be sure to research individual companies thoroughly, consider the risks and rewards, and consult with a financial advisor to make informed decisions.
When investing in drug manufacturer stocks, it's essential to consider the company's track record of innovation, pipeline of products in development, regulatory challenges, competition, and market trends.
You can stay informed about developments in the drug manufacturing industry by following healthcare news outlets, attending industry conferences, monitoring company earnings reports, and consulting with financial experts who specialize in healthcare investments.
Yes, drug manufacturer stocks can be influenced by changes in healthcare policies, such as pricing regulations, reimbursement rates, and government healthcare spending. It's essential to stay informed about these policies and their potential impact on the industry.